Michael Thomas Henderson
Officer, BridgeBio.
Companies
- Apogee Therapeutics, Inc.Board member Jul 13, 2023 to now1
- Apogee Therapeutics, Inc.Chief executive officer Jul 13, 2023 to now1
- Aeglea BioTherapeuticsBoard member Jun 30, 2023 to now2
- ARYA Sciences Acquisition Corp IVBoard member Feb 25, 2021 to Jul 31, 20243
- BridgeBioOfficer Jun 27, 2019 to Dec 17, 20204
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aeglea BioTherapeutics SYRE68,606 shares5$5.4M at $79.33Jun 22, 2026
- Apogee Therapeutics, Inc.0 shares6Sep 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 3, 2026Returned to company 920,941 shares of Apogee Therapeutics, Inc.6
- Jul 10, 2026Gift 75,046 shares of Apogee Therapeutics, Inc.7
- Jul 8, 2026Sold 20,000 shares at $133.63 of Apogee Therapeutics, Inc.7
- Jun 22, 2026Sold 20,000 shares at $100.00 of Aeglea BioTherapeutics5
- Jun 22, 2026Sold 80,000 shares at $132.54 of Apogee Therapeutics, Inc.8
- Jun 10, 2026Sold 614 shares at $86.89 of Apogee Therapeutics, Inc.9
- Jun 10, 2026Sold 2,305 shares at $86.27 of Apogee Therapeutics, Inc.9
- Jun 10, 2026Sold 1,577 shares at $85.19 of Apogee Therapeutics, Inc.9
- Jun 10, 2026Sold 1,080 shares at $84.18 of Apogee Therapeutics, Inc.9
- Jun 10, 2026Sold 7,654 shares at $82.78 of Apogee Therapeutics, Inc.9
- Jun 10, 2026Sold 6,770 shares at $82.21 of Apogee Therapeutics, Inc.9
- May 13, 2026Sold 1,341 shares at $82.58 of Apogee Therapeutics, Inc.10
- May 13, 2026Sold 18,659 shares at $82.05 of Apogee Therapeutics, Inc.10
- May 8, 2026Sold 19,269 shares at $75.35 of Aeglea BioTherapeutics11
- May 8, 2026Sold 24,814 shares at $74.76 of Aeglea BioTherapeutics11
- May 8, 2026Sold 33,513 shares at $73.72 of Aeglea BioTherapeutics11
- May 8, 2026Sold 2,404 shares at $72.57 of Aeglea BioTherapeutics11
- Apr 16, 2026Exercised options 3,000 shares at $22.86 of Apogee Therapeutics, Inc.12
- Apr 8, 2026Sold 200 shares at $85.00 of Apogee Therapeutics, Inc.13
- Apr 8, 2026Sold 2,000 shares at $83.26 of Apogee Therapeutics, Inc.13
- Apr 8, 2026Sold 17,800 shares at $82.48 of Apogee Therapeutics, Inc.13
- Mar 11, 2026Sold 3,418 shares at $75.86 of Apogee Therapeutics, Inc.14
- Mar 11, 2026Sold 8,219 shares at $74.83 of Apogee Therapeutics, Inc.14
- Mar 11, 2026Sold 8,363 shares at $74.29 of Apogee Therapeutics, Inc.14
- Feb 11, 2026Sold 955 shares at $64.99 of Apogee Therapeutics, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAeglea BioTherapeutics, Board member
- 3
- 4SEC EDGARBridgeBio, Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Jul 10, 2026
- 8SEC EDGARForm 4 filed Jun 24, 2026
- 9SEC EDGARForm 4 filed Jun 12, 2026
- 10SEC EDGARForm 4 filed May 15, 2026
- 11SEC EDGARForm 4 filed May 8, 2026
- 12SEC EDGARForm 4 filed Apr 20, 2026
- 13SEC EDGARForm 4 filed Apr 10, 2026
- 14SEC EDGARForm 4 filed Mar 13, 2026
- 15SEC EDGARForm 4 filed Feb 13, 2026